Cargando…

Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan

BACKGROUND: Genetic variants could be identified in subjects with idiopathic and heritable pulmonary arterial hypertension (PAH). The 6th World Symposium on Pulmonary Hypertension (WSPH) provided a list of genes with evidence of association with PAH. However, reports using whole exome sequencing (WE...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Kae-Woei, Chang, Sheng-Kai, Chen, Yu-Wei, Lin, Wei-Wen, Tsai, Wan-Jane, Wang, Kuo-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256950/
https://www.ncbi.nlm.nih.gov/pubmed/35811711
http://dx.doi.org/10.3389/fcvm.2022.911649
_version_ 1784741226770071552
author Liang, Kae-Woei
Chang, Sheng-Kai
Chen, Yu-Wei
Lin, Wei-Wen
Tsai, Wan-Jane
Wang, Kuo-Yang
author_facet Liang, Kae-Woei
Chang, Sheng-Kai
Chen, Yu-Wei
Lin, Wei-Wen
Tsai, Wan-Jane
Wang, Kuo-Yang
author_sort Liang, Kae-Woei
collection PubMed
description BACKGROUND: Genetic variants could be identified in subjects with idiopathic and heritable pulmonary arterial hypertension (PAH). The 6th World Symposium on Pulmonary Hypertension (WSPH) provided a list of genes with evidence of association with PAH. However, reports using whole exome sequencing (WES) from southeastern Asian PAH cohorts were scarce. METHODS: Subjects with idiopathic and heritable PAH (N = 45) from two medical centers in central Taiwan were screened for PAH related gene variants. The genomic DNA was prepared from peripheral blood lymphocytes. We performed WES for all patients enrolled in this study. All identified gene variants were validated by polymerase-chain reaction and Sanger sequencing. The clinical and hemodynamic data were compared between bone morphogenetic protein receptor type-2 (BMPR2) gene variants carriers vs. non-carriers. RESULTS: Eight patients (8/45 = 17.8%) was identified carrying BMPR2 gene variants and 8 patients (8/45 = 17.8%) had other WSPH-listed PAH-related gene variants (1 with ACVRL1, 1 with ENG, 1 with SMAD9, 1 with SMAD1, 1 with ATP13A3 and 3 with AQP1). In addition, a total of 14 non-WSPH-listed PAH-related genetic variant sites (ABCC8, NOTCH1, NOTCH2, NOTCH3, JAG1, BMP10, GGCX, FBLN2, ABCA3 and PTGIS) were found in this PAH cohort. Subjects carrying BMPR2 gene variant (N = 8) were younger at diagnosis of PAH (30 ± 11 vs 49 ± 13 years, p = 0.001) than the non-carrier group (N = 37). BMPR2 variant carriers had a trend toward having higher mean pulmonary arterial pressure (PAP) (61 ± 19 vs. 51 ± 13 mmHg, p = 0.076) than the non-carriers upon initial diagnosis. Pulmonary vascular resistance, right atrial pressure, cardiac output, as well as functional class were similar between BMPR2 variant carriers and non-carriers at initial diagnosis. CONCLUSIONS: We identified 17.8% of patients with BMPR2 gene variants and 17.8% subjects with other 6th WSPH-listed PAH-related gene variants in a Taiwanese idiopathic and heritable PAH cohort. PAH patients carrying BMPR2 variants presented at a younger age with a trend toward having higher mean PAP at initial diagnosis.
format Online
Article
Text
id pubmed-9256950
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92569502022-07-07 Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan Liang, Kae-Woei Chang, Sheng-Kai Chen, Yu-Wei Lin, Wei-Wen Tsai, Wan-Jane Wang, Kuo-Yang Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Genetic variants could be identified in subjects with idiopathic and heritable pulmonary arterial hypertension (PAH). The 6th World Symposium on Pulmonary Hypertension (WSPH) provided a list of genes with evidence of association with PAH. However, reports using whole exome sequencing (WES) from southeastern Asian PAH cohorts were scarce. METHODS: Subjects with idiopathic and heritable PAH (N = 45) from two medical centers in central Taiwan were screened for PAH related gene variants. The genomic DNA was prepared from peripheral blood lymphocytes. We performed WES for all patients enrolled in this study. All identified gene variants were validated by polymerase-chain reaction and Sanger sequencing. The clinical and hemodynamic data were compared between bone morphogenetic protein receptor type-2 (BMPR2) gene variants carriers vs. non-carriers. RESULTS: Eight patients (8/45 = 17.8%) was identified carrying BMPR2 gene variants and 8 patients (8/45 = 17.8%) had other WSPH-listed PAH-related gene variants (1 with ACVRL1, 1 with ENG, 1 with SMAD9, 1 with SMAD1, 1 with ATP13A3 and 3 with AQP1). In addition, a total of 14 non-WSPH-listed PAH-related genetic variant sites (ABCC8, NOTCH1, NOTCH2, NOTCH3, JAG1, BMP10, GGCX, FBLN2, ABCA3 and PTGIS) were found in this PAH cohort. Subjects carrying BMPR2 gene variant (N = 8) were younger at diagnosis of PAH (30 ± 11 vs 49 ± 13 years, p = 0.001) than the non-carrier group (N = 37). BMPR2 variant carriers had a trend toward having higher mean pulmonary arterial pressure (PAP) (61 ± 19 vs. 51 ± 13 mmHg, p = 0.076) than the non-carriers upon initial diagnosis. Pulmonary vascular resistance, right atrial pressure, cardiac output, as well as functional class were similar between BMPR2 variant carriers and non-carriers at initial diagnosis. CONCLUSIONS: We identified 17.8% of patients with BMPR2 gene variants and 17.8% subjects with other 6th WSPH-listed PAH-related gene variants in a Taiwanese idiopathic and heritable PAH cohort. PAH patients carrying BMPR2 variants presented at a younger age with a trend toward having higher mean PAP at initial diagnosis. Frontiers Media S.A. 2022-06-22 /pmc/articles/PMC9256950/ /pubmed/35811711 http://dx.doi.org/10.3389/fcvm.2022.911649 Text en Copyright © 2022 Liang, Chang, Chen, Lin, Tsai and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Liang, Kae-Woei
Chang, Sheng-Kai
Chen, Yu-Wei
Lin, Wei-Wen
Tsai, Wan-Jane
Wang, Kuo-Yang
Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan
title Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan
title_full Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan
title_fullStr Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan
title_full_unstemmed Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan
title_short Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan
title_sort whole exome sequencing of patients with heritable and idiopathic pulmonary arterial hypertension in central taiwan
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256950/
https://www.ncbi.nlm.nih.gov/pubmed/35811711
http://dx.doi.org/10.3389/fcvm.2022.911649
work_keys_str_mv AT liangkaewoei wholeexomesequencingofpatientswithheritableandidiopathicpulmonaryarterialhypertensionincentraltaiwan
AT changshengkai wholeexomesequencingofpatientswithheritableandidiopathicpulmonaryarterialhypertensionincentraltaiwan
AT chenyuwei wholeexomesequencingofpatientswithheritableandidiopathicpulmonaryarterialhypertensionincentraltaiwan
AT linweiwen wholeexomesequencingofpatientswithheritableandidiopathicpulmonaryarterialhypertensionincentraltaiwan
AT tsaiwanjane wholeexomesequencingofpatientswithheritableandidiopathicpulmonaryarterialhypertensionincentraltaiwan
AT wangkuoyang wholeexomesequencingofpatientswithheritableandidiopathicpulmonaryarterialhypertensionincentraltaiwan